Department of Pediatrics and Neonatology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.
Department of Pediatrics, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
J Pediatr Endocrinol Metab. 2020 May 29;33(6):691-701. doi: 10.1515/jpem-2019-0433.
Objectives Congenital hypothyroidism (CH) is the most common congenital endocrine disorder. Recent advances in genetic testing have revealed its causative mutations in some CH patients. However, the underlying etiology remains unknown in most patients. This study aimed to perform clinical and genetic investigation in Japanese CH patients to uncover genotype-phenotype correlations. Methods We enrolled 136 Japanese patients with transient or permanent CH between April 2015 and March 2017, and performed next-generation sequencing of 19 genes implicated in CH. Results We identified potentially pathogenic bi-allelic variants in DUOX2, TSHR, and TPO in 19, 5, and 1 patient, respectively (autosomal recessive), and a potentially pathogenic mono-allelic variant in NKX2-1 (autosomal dominant) in 1 patient. Molecular genetic diagnosis was highly suggested in 26 patients (19%) from 23 families. We also detected a potentially pathogenic mono-allelic variant in five recessive genes (DUOX2, TSHR, TG, DUOXA2, and TPO) in 31 unrelated patients (23%), although the pathogenicity of these variants remains inconclusive. Patients with bi-allelic DUOX2 variants showed a more severe clinical presentation in infancy than those with bi-allelic TSHR variants. However, this trend reversed beyond infancy. There were no statistical differences in initial thyroid stimulating hormone, free thyroxine, thyroglobulin, and levothyroxine dose as of March 2017 between patients with bi-allelic and mono-allelic DUOX2 variants. Conclusions The prevalence of potentially-pathogenic variants in Japanese CH patients was similar to that found by previous reports. Our study demonstrates a genotype-phenotype correlation in Japanese CH patients.
目的 先天性甲状腺功能减退症(CH)是最常见的先天性内分泌疾病。遗传检测的最新进展揭示了一些 CH 患者的致病突变。然而,大多数患者的潜在病因仍不清楚。本研究旨在对日本 CH 患者进行临床和遗传研究,以揭示基因型-表型相关性。
方法 我们招募了 2015 年 4 月至 2017 年 3 月期间患有暂时性或永久性 CH 的 136 名日本患者,并对 19 个与 CH 相关的基因进行了下一代测序。
结果 我们在 19 名、5 名和 1 名患者中分别发现了双等位基因变体(常染色体隐性遗传),在 1 名患者中发现了一个潜在致病的单等位基因变体(常染色体显性遗传)(DUOX2、TSHR 和 TPO)。在 23 个家系的 26 名患者(19%)中高度提示存在分子遗传学诊断。我们还在 31 名无亲缘关系的患者中检测到 5 个隐性基因(DUOX2、TSHR、TG、DUOXA2 和 TPO)中的潜在致病单等位基因变体(23%),尽管这些变体的致病性仍不确定。具有双等位基因 DUOX2 变体的患者在婴儿期的临床表现比具有双等位基因 TSHR 变体的患者更为严重。然而,这种趋势在婴儿期后发生逆转。截至 2017 年 3 月,具有双等位基因和单等位基因 DUOX2 变体的患者的初始促甲状腺激素、游离甲状腺素、甲状腺球蛋白和左甲状腺素剂量之间无统计学差异。
结论 日本 CH 患者潜在致病性变异的患病率与以往报道相似。我们的研究表明日本 CH 患者存在基因型-表型相关性。